Reported about 11 hours ago
Kimberly-Clark is set to acquire Kenvue, the maker of Tylenol, in a deal valued at approximately $48.7 billion, which will form a significant consumer health goods company. Following the merger, Kimberly-Clark shareholders will hold 54% of the new entity while Kenvue shareholders will hold 46%. The combined company will feature a wide range of household brands and is expected to generate $32 billion in annual revenue. The transaction is pending shareholder approval and is slated to close in the second half of next year.
Source: YAHOO